Fig. 6From: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group RegistryThe effect of TKI access over time on overall survival of GIST patients. a Most commonly used drugs, 3rd line and beyond by year started 3rd line. b OS from start of 3rd line by time periodBack to article page